Background. A major cause of the increase in antimicrobial resistance is the inappropriate
. During the past decades, the use of broad-spectrum antimicrobials in Gastroenterology Departments increased, particularly among patients with cirrhosis and spontaneous bacterial peritonitis (SBP). Bacterial infection is present in 32%-34% of hospitalized patients with cirrhosis, which is 4 to 5 fold higher than hospitalized patients in general, and it accounts for about 30%-50% of deaths [7] [8] [9] . Common types of infections in patients with cirrhosis include SBP (25%-31%), urinary tract infection (UTI) (20%-25%), pneumonia (15%-21%), bacteremia (12%), and soft tissue infection (11%) [10] [11] [12] . The major causative organisms are gram-negative bacteria, e.g., Escherichia coli, Klebsiella spp. and Enterobacter spp., whereas gram-positive bacteria comprise about 20%, and anaerobes only 3% [10] . In a large prospective study of cirrhotic patients with infections, multi-drug resistant (MDR) bacteria were isolated in 4%, 14%, and 35% of community-acquired,
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A c c e p t e d M a n u s c r i p t 3 healthcare-associated, and nosocomial infections, respectively (P < 0.001) [13] . The main resistant organisms were extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, followed by Pseudomonas aeruginosa, methicillin-resistant S. aureus (MRSA), and Enterococcus faecium [13] . There was a significantly higher incidence of septic shock and death from infections caused by resistant bacteria. Notably, the efficacy of empirical antibiotic treatment was decreased in nosocomial infections (40%), compared to community-acquired and healthcare-associated episodes (83% and 73%, respectively; P<0.0001), especially in SBP, UTI, and pneumonia (26%, 29% and 44%, respectively) [13] . Infectious diseases (ID) consultation has an important role in reducing inappropriate antimicrobial use [14] [15] [16] . 
METHODS
This was an observational prospective study evaluating, after 12 months of intervention, Case-audits took on average between 10 and 15 minutes, including administration time. 
DISCUSSION
ID services play an important role in improving antimicrobial use by providing expert advice on the appropriate use of antimicrobial agents, education to prescribers, and developing and implementing evidence-based guidelines. It was suggested that consultation with an ID specialist is one of the six clinical strategies to reduce inadequate antimicrobial treatment in the hospital setting [19] . Many studies demonstrated improved patient outcomes when ID physicians were involved in the care of patients with bacteraemia, with the advantage of reducing morbidity, mortality, and cost of care [14] .
Indeed, a previous study from our institution showed that ID consultation led to cost reduction by advising less expensive antibiotics and reducing third-and fourth-generation cephalosporins, piperacillin/tazobactam, teicoplanin, and parenteral quinolones [20] . To our knowledge, this is the first study on antimicrobial stewardship in a Gastroenterology , and in a Turkish hospital the therapy was changed in 57.4% of patients and antibiotics were not necessary for 9.8% [22] . This finding is consistent with previous studies where the use of antimicrobial therapy was judged to be inappropriate or required change. In a study by Yinnon et al [23] there was a change of therapy or discontinuation of antibiotics in 46%. Other studies found that 41-66% of antibiotic was changed after ID consultation [24, 25] .
Second, the ASP had a positive impact on the consumption of antibiotics and antifungals, especially as regards carbapenems, quinolones, glycopeptides and echinocandins. One of the main reasons why we selected the Gastroenterology Department forthe ASP was that it had a very high consumption of carbapenems (up 30 DDDs /100pd) during the past years. This was mainly due to the fact that since 2011 an increase of infection and colonization rates of ESBL-positive Enterobacteriaceae was observed in our hospital and the first-line empirical treatment in cirrhotic patients with sepsis or PBS was changed from ceftriaxone to meropenem. Therefore, the ASP was focused especially in reducing the carbapenems and quinolones consumption. An important result of our study is that the reduction in broad-spectrum antibiotic consumption was not associated with an increase in LOS and, in mortality rate. Moreover, the incidence of MDR bacterial infections decreased during the ASP implementation period, even if it did not reach statistical significance. This could indicate that a reduction in the use of broad-spectrum antibiotics may have contributed a lower selection of MDR bacteria.
Objective of the case-audit was to reach a consensus-based agreement between the ID specialist and the physician at the ward, using (local) guidelines, available diagnostics and the expertise and experience of both physicians. This should optimize antimicrobial
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A c c e p t e d M a n u s c r i p t 9 treatment. The case-audit focused on the improvement of patient care through relatively easy to achieve improvements after a few days of therapy, such as early de-escalation of antimicrobial therapy and stop when there was no longer an indication. Furthermore, the face-to-face case-audit on the ward provided an extra opportunity for questions about appropriateness of therapy and requesting additional consultations for other patients on the ward.
Our study confirms that cirrhosis is one of the main reasons for admission in Gastroenterology Department. The patients with cirrhosis accounted for the 51.13% of the study population and resulted to have a higher LOS and in-hospital mortality rate. Arvaniti et al. demonstrated that bacterial infections in cirrhosis are associated with poorer outcome and that mortality increased about 4 fold [26] . Both short-and long-term mortality rates of sepsis in cirrhotic patients are very high; 26%-44% of patients die within 1 month after infection and another 33% die in 1 year [26, 27] . Also we observed a poorer outcome in the patients with cirrhosis and bacterial infections, and despite an effective antimicrobial treatment, 50.0% of these patients died within 15 days after infection. Factors that must to be taken into account as predictors of death during or following infection are: advanced liver disease, nosocomial origin, gastrointestinal haemorrhage, encephalopathy, liver cancer, presence of shock and organ failure (especially renal failure) [26, 27] .
Our study has some limitations. Effects of ASP were evaluated for a Gastroenterology Department in a single academic setting and it does not allow general considerations.
Nevertheless, we think that in the absence of any data even a study conducted on a single
Gastroenterology department could give important information. Moreover, a
Gastroenterology department due to the severity of its case mix and the peculiarity of cirrhotic patients could represent a good example of how ASP could be implemented also in setting treating more complicated patients.
Another important limitation was that the comparison of LOS and the mortality rate in the 2
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In conclusion, ASP interventions are beneficial without showing any negative impact on survival by reducing the use of broad-spectrum antibiotics and for this reason it should be promoted throughout the hospital departments.
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